Anthropic releases Claude Science, a product aimed at researchers, the pharma industry - statnews.com

Biotech Anthropic releases Claude Science, a product aimed at researchers, the pharma industry The AI giant is seeking to fundamentally upend the life sciences Manage alerts for this article Email this article Share this article Anthropic CEO Dario Amodei, left, with scientist Lotte Bjerre Knudsen and STAT’s Matthew Herper at an event to discuss Claude Science in San Francisco.Anthropic By Matthew Herper and Brittany Trang Matthew Herper covers medical innovation — both its promise and its perils. Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be harmed? She writes the weekly AI Prognosis newsletter. Follow her on Threads, Mastodon, and Bluesky. You can reach Brittany on Signal at btrang.01. SAN FRANCISCO — Anthropic, the artificial intelligence firm, on Tuesday announced the availability of Claude Science, an application that optimizes the company’s large language model for use in scientific laboratories and, especially, within the research operations of pharmaceutical companies. At a launch event here, Anthropic CEO Dario Amodei said that until now, humans have wrestled with the complexity of biology only with their minds. While biology is not as simple or clean as code, he still thinks it can be just as powerful in this domain. “It’s going to be a general purpose technology that helps us to make sense of that complexity, in its full complexity, better.” But, he admitted, “We don’t know for sure if that’s going to work out. But I think we’re seeing signs that we’re seeing the beginnings of it.” To read the rest of this story